Insiders trading at Kinnate Biopharma

Over the last 3 years, insiders at Kinnate Biopharma have traded over $0 worth of Kinnate Biopharma stock and bought 12,223,600 units worth $79,803,534 . The most active insiders traders include Carl L Gordon, Advisors Llc Orbi Med Capit..., and Advisors Llc Orbi Med Capit.... On average, Kinnate Biopharma executives and independent directors trade stock every 74 days with the average trade being worth of $2,658,632. The most recent stock trade was executed by James B. Tananbaum on 8 May 2023, trading 1,780,000 units of KNTE stock currently worth $4,984,000.